An Open-label, Single Arm, Sequential, Single Centre Trial Investigating the Influence of Oral Semaglutide (NNC0113-0217) on Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2017
At a glance
- Drugs Semaglutide (Primary) ; Lisinopril; Warfarin
- Indications Cardiovascular disorders; Multiple sclerosis; Thromboembolism; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association
- 25 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 May 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.